Ran Wu Selected Research

Ruthenium Red

1/2022	Glucose-Dependent Insulinotropic Polypeptide and Substance P Mediate Emetic Response Induction by Masked Trichothecene Deoxynivalenol-3-Glucoside through Ca2+ Signaling.
1/2022	Emetic Response to T-2 Toxin Correspond to Secretion of Glucagon-like Peptide-17-36 Amide and Glucose-Dependent Insulinotropic Polypeptide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ran Wu Research Topics

Disease

21	Neoplasms (Cancer) 05/2024 - 09/2003
15	Alcoholism (Alcohol Abuse) 11/2021 - 07/2003
6	Reperfusion Injury 09/2023 - 01/2013
5	Inflammation (Inflammations) 01/2024 - 10/2017
4	Squamous Cell Carcinoma of Head and Neck 03/2023 - 01/2021
4	Ischemia 02/2020 - 01/2013
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2017 - 04/2015
3	Weight Gain 10/2010 - 03/2006
2	Lymphoma (Lymphomas) 01/2023 - 12/2018
2	COVID-19 08/2022 - 04/2021
2	Vomiting 01/2022 - 01/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020 - 05/2017
2	Lung Neoplasms (Lung Cancer) 11/2020 - 08/2014
2	Fibrosis (Cirrhosis) 02/2020 - 10/2019
2	Nasopharyngeal Carcinoma 10/2016 - 03/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2015 - 08/2014
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 07/2008 - 06/2006
1	Drug Eruptions (Drug Eruption) 10/2023
1	Vitiligo 10/2023
1	Sigmoid Neoplasms 10/2023
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 10/2023
1	Exanthema (Rash) 10/2023
1	Pruritus (Itching) 10/2023
1	Erythema Multiforme 10/2023
1	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2023
1	Hodgkin Disease (Hodgkin's Disease) 01/2023
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023
1	Ascites 10/2022
1	Underactive Urinary Bladder 01/2022
1	Foodborne Diseases 01/2022
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 01/2022

Drug/Important Bio-Agent (IBA)

10	Naltrexone (ReVia)FDA LinkGeneric 02/2015 - 07/2003
6	MicroRNAs (MicroRNA)IBA 01/2017 - 03/2015
5	Varenicline (Chantix)FDA Link 11/2021 - 06/2011
4	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2018
4	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2015
3	Erythropoietin FDA Link 09/2023 - 02/2015
3	Nicotine FDA Link 01/2019 - 07/2008
2	InterferonsIBA 01/2024 - 08/2023
2	EmeticsIBA 01/2022 - 01/2022
2	Therapeutic UsesIBA 01/2022 - 01/2021
2	mitochondrial calcium uniporterIBA 01/2022 - 01/2021
2	Peptides (Polypeptides)IBA 01/2022 - 01/2022
2	Ruthenium RedIBA 01/2022 - 01/2022
2	SmokeIBA 04/2021 - 08/2007
2	HLA-B Antigens (HLA-B)IBA 12/2016 - 10/2016
2	HLA-A Antigens (HLA-A)IBA 10/2016 - 03/2014
2	HLA Antigens (Human Leukocyte Antigens)IBA 10/2016 - 08/2014
2	erucylphosphocholineIBA 04/2015 - 09/2014
2	AntioxidantsIBA 04/2015 - 08/2014
2	BilirubinIBA 04/2015 - 08/2014
2	Sertraline (Zoloft)FDA LinkGeneric 01/2009 - 07/2008
1	sintilimabIBA 10/2023
1	Interleukin-23 (Interleukin 23)IBA 08/2023
1	Imiquimod (Aldara)FDA LinkGeneric 08/2023
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 08/2023
1	Interleukin-22 (IL-22)IBA 08/2023
1	Interleukin-17 (Interleukin 17)IBA 08/2023
1	AntibodiesIBA 08/2023
1	Interleukin-12 (IL 12)IBA 08/2023
1	Interleukin-8 (Interleukin 8)IBA 08/2023
1	EnzymesIBA 08/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 08/2023
1	CytokinesIBA 08/2023
1	Interleukin-4 (Interleukin 4)IBA 08/2023
1	Hematoxylin (Haematoxylon)IBA 08/2023
1	ImmunosorbentsIBA 08/2023
1	Interleukin-2 (IL2)IBA 08/2023
1	Receptors for Activated C KinaseIBA 03/2023
1	Etoposide (VP 16)FDA LinkGeneric 01/2023
1	Carmustine (FIVB)FDA Link 01/2023
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023
1	Bendamustine Hydrochloride FDA Link 01/2023
1	Melphalan (Alkeran)FDA LinkGeneric 01/2023
1	AlbuminsIBA 10/2022
1	T-2 Toxin (T 2 Toxin)IBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	CalciumIBA 01/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022
1	TrichothecenesIBA 01/2022
1	artenimol (dihydroartemisinin)IBA 01/2022
1	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Glucagon (Glukagon)FDA Link 01/2022
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2022
1	deoxynivalenolIBA 01/2022
1	SARS-CoV-2 spike proteinIBA 04/2021
1	Oncogene Proteins (Oncogene Protein)IBA 04/2021
1	CarcinogensIBA 04/2021

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 01/2023 - 07/2008
7	Therapeutics 01/2022 - 03/2006
5	Transplantation 09/2023 - 01/2016
3	Nephrectomy 02/2020 - 01/2013
2	Immunotherapy 05/2024 - 02/2024
2	Radiotherapy 12/2020 - 05/2018
1	Intraperitoneal Injections 08/2023
1	Stem Cell Transplantation 01/2023
1	Meditation 08/2022